Granules India share price
You have to be logged in to add this to Watchlist.- ₹484.45(0.82%)April 23, 2025 15:29:44 PM IST
- NSE
- BSE
- Vol : 2.37M (NSE + BSE)Last 20 day avg : 1.16 M
Granules India is trading 0.82% upper at Rs 484.45 as compared to its last closing price. Granules India has been trading in the price range of 488.25 & 471.70. Granules India has given -18.93% in this year & 11.39% in the last 5 days. Granules India has TTM P/E ratio 29.95 as compared to the sector P/E of 28.79.There are 4 analysts who have initiated coverage on Granules India. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 117.60 Crores in its last quarter.Listed peers of Granules India include Caplin Point Laboratories (-0.12%), Alivus Life Sciences (0.35%), Granules India (0.82%).The Mutual Fund holding in Granules India was at 11.57% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Granules India was at 15.14% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 23, 2025, 03:50 PM UTC
- Dividend YieldLower than industry0.31Annual dividends as a percentage of the stock price.
- P/BHigher than historical values3.61The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values24.31Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-2.80The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- BetaLow volatility0.73Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.41The debt-to-equity ratio, indicating a company's financial leverage.
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable
The company's revenue fell during December quarter by 1.55% from Rs 1155.58 crore to Rs 1137.70 crore, year-on-year- The company's profit declined by 6.41% year-on-year during the December quarter, dropping from Rs 125.65 crore to Rs 117.60 crore
- The debt to equity of the company is higher than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 519.78
- R2
- 556.37
- R3
- 610.23
- S1
- 429.33
- S2
- 375.47
- S3
- 338.88
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Caplin Point Laboratories | Bearish | 1,887.90 | -0.12 | 14,450.63 | 31.79 | 6.25 | 0.26 | 0.04 |
| Alivus Life Sciences | Neutral | 1,026.90 | 0.35 | 12,612.71 | 26.41 | 5.33 | 2.22 | 0.63 |
| Granules India | Neutral | 484.45 | 0.82 | 11,815.75 | 28.59 | 3.61 | 0.31 | 4.72 |
| Marksans Pharma | Neutral | 215.65 | 0.65 | 9,763.26 | 29.78 | 4.7 | 0.28 | 9.20 |
| Procter & Gamble Health | Moderately Bearish | 5,239.60 | 1.45 | 8,682.63 | 39.81 | 16.11 | 2.68 | 1.28 |
- Promoter(s) holding is moderate at 38.84%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 0.73 percentage points from previous quarter
- Mutual Funds holding has increased by 1.18 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-01-24 | Quarterly Results |
| 2024-11-06 | Quarterly Results |
| 2024-07-30 | Quarterly Results |
| 2024-05-15 | Audited Results & Final Dividend |
| 2024-01-23 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE101D01020
- BSE Code532482
- NSE CodeGRANULES
Granules India is trading at 484.45 as on Wed Apr 23 2025 09:59:44. This is 0.82% upper as compared to its previous closing price of 480.50.
The market capitalization of Granules India is 11815.75 Cr as on Wed Apr 23 2025 09:59:44.
The average broker rating on Granules India is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Granules India is 724.55 whereas the 52 wk low is 389.15
Granules India can be analyzed on the following key metrics -
- TTM P/E: 29.95
- Sector P/E: 28.79
- Dividend Yield: 0.31%
- D/E ratio: -
Granules India reported a net profit of 405.31 Cr in 2024.
The Mutual Fund Shareholding was 11.57% at the end of 31 Mar 2025.